bullish
China Feihe (中国飞鹤) IPO Trading - Allocation, Peer Performance, and Upside
484 Views13 Nov 2019 11:46
China Feihe, the largest domestic infant milk formula (IMF) player, raised USD 847 million at HKD 7.50 per share. In this insight, we will cover...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Trade Idea: China Feihe's Top Line Could Beat Today04 Mar 2020
- China Feihe (中国飞鹤) Post-IPO: Thoughts on Official Response to Short Seller Report25 Nov 2019
- China Feihe (中国飞鹤) Post-IPO: Thoughts on Short Seller Allegations22 Nov 2019
- China Feihe (中国飞鹤) IPO - Wide Valuation Range, No Cornerstone, and Things to Note28 Oct 2019
- China Feihe (中国飞鹤) IPO: Peer Comparison and Thoughts on Valuation16 Oct 2019
x